New HIV vaccine ‘based on Moderna’s COVID jab’ shows huge promise after first human trials
Published
A new vaccine has shown huge promise in the fight against HIV with the treatment successfully stimulating the production of antibodies in human trials. The novel vaccine stimulated the production of rare immune cells needed to generate antibodies against HIV in 97 per cent of participants in phase one of human trials. This...
Full Article